Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells

Current Opinion in Organ Transplantation

Volumn 19, Issue 4, 2014, Pages 348-356

  Morelli, Adrian E ^a,b   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cell therapy; Dendritic cells; Transplant tolerance

Indexed keywords

ANTIGEN;

ALLOIMMUNITY; CELL THERAPY; DENDRITIC CELL; DONOR; DRUG TARGETING; EX VIVO STUDY; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; NONHUMAN; ORGAN TRANSPLANTATION; PRIMATE; REVIEW; T LYMPHOCYTE; ALLOTRANSPLANTATION; ANIMAL; IMMUNOLOGY; TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

ANIMALS; DENDRITIC CELLS; GRAFT SURVIVAL; HUMANS; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84904210524     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000097     Document Type: Review

References (55)

1. Thomson AW, Lu L, Murase N, et al. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995; 13:622-639.
2. Steptoe RJ, Thomson AW. Dendritic cells and tolerance induction. Clin Exp Immunol 1996; 105:397-402.
3. Rastellini C, Lu L, Ricordi C, et al. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60:1366-1370.
4. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62:659-665.
5. Lu L, Li W, Fu F, et al. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 1997; 64:1808-1815.
6. Mascanfroni ID, Yeste A, Vieira SM, et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat Immunol 2013; 14:1054-1063.
7. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7:610-621.
8. Ezzelarab M, Thomson AW. Tolerogenic dendritic cells and their role in transplantation. Semin Immunol 2011; 23:252-263.
9. Moreau A, Varey E, Beriou G, et al. Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials. Front Immunol 2012; 3:218.
10. Sun G, Shan J, Li Y, et al. Adoptive infusion of tolerogenic dendritic cells prolongs the survival of pancreatic islet allografts: a systematic review of 13 mouse and rat studies. PLoS One 2012; 7:e52096.
11. Vassalli G. Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation. J Transplant 2013; 2013:761429.
12. Svajger U, Rozman P. Tolerogenic dendritic cells: molecular and cellular mechanisms in transplantation. J Leukoc Biol 2014; 95:53-69.
13. Gordon JR, Ma Y, Churchman L, et al. Regulatory dendritic cells for immunotherapy in immunologic diseases. Front Immunol 2014; 5:7.
14. Rogers NM, Isenberg JS, Thomson AW. Plasmacytoid dendritic cells: no longer an enigma and now key to transplant tolerance? Am J Transplant 2013; 13:1125-1133.
15. Divito SJ, Wang Z, Shufesky WJ, et al. Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation. Blood 2010; 116:2694-2705.
16. Wang Z, Divito SJ, Shufesky WJ, et al. Dendritic cell therapies in transplantation revisited: deletion of recipient DCs deters the effect of therapeutic DCs. Am J Transplant 2012; 12:1398-1408.
17. Hattori T, Saban DR, Emami-Naeini P, et al. Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitizationdominant setting of corneal transplantation. J Leukoc Biol 2012; 91:621-627.
18. Khan A, Fu H, Tan LA, et al. Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur J Immunol 2013; 43:734-746.
19. Smyth LA, Ratnasothy K, Moreau A, et al. Tolerogenic donor-derived dendritic cells risk sensitization in vivo owing to processing and presentation by recipient APCs. J Immunol 2013; 190:4848-4860.
20. de Kort H, Crul C, van der Wal AM, et al. Accelerated antibody-mediated graft loss of rodent pancreatic islets after pretreatment with dexamethasonetreated immature donor dendritic cells. Transplantation 2012; 94:903-910.
21. Ezzelarab MB, Zahorchak AF, Lu L, et al. Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. Am J Transplant 2013; 13:1989-2005.
22. Beriou G, Moreau A, Cuturi MC. Tolerogenic dendritic cells: applications for solid organ transplantation. Curr Opin Organ Transplant 2012; 17:42-47.
23. Beriou G, Peche H, Guillonneau C, et al. Donor-specific allograft tolerance by administration of recipient-derived immature dendritic cells and suboptimal immunosuppression. Transplantation 2005; 79:969-972.
24. Hill M, Thebault P, Segovia M, et al. Cell therapy with autologous tolerogenic dendritic cells induces allograft tolerance through interferon-gamma and epstein-barr virus-induced gene 3. Am J Transplant 2011; 11:2036-2045.
25. Segovia M, Louvet C, Charnet P, et al. Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation. Am J Transplant 2014; 14:1021-1031. (In press).
26. Thomas DC, Wong FS, Zaccone P, et al. Protection of islet grafts through transforming growth factor-beta-induced tolerogenic dendritic cells. Diabetes 2013; 62:3132-3142.
27. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21:685-711.
28. Morelli AE, Larregina AT. Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells. Apoptosis 2010; 15:1083-1097.
29. Sun E, Gao Y, Chen J, et al. Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient. Cell Death Differ 2004; 11:1258-1264.
30. Wang Z, Larregina AT, Shufesky WJ, et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant 2006; 6:1297-1311.
31. Wang Z, Shufesky WJ, Montecalvo A, et al. In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS One 2009; 4:e4940.
32. Montecalvo A, Shufesky WJ, Stolz DB, et al. Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. J Immunol 2008; 180:3081-3090.
33. Montecalvo A, Larregina AT, Shufesky WJ, et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 2012; 119:756-766.
34. Li X, Li JJ, Yang JY, et al. Tolerance induction by exosomes from immature dendritic cells and rapamycin in a mouse cardiac allograft model. PLoS One 2012; 7:e44045.
35. Dudziak D, Kamphorst AO, Heidkamp GF, et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007; 315:107-111.
36. Bonifaz L, Bonnyay D, Mahnke K, et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002; 196:1627-1638.
37. Mukhopadhaya A, Hanafusa T, Jarchum I, et al. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc Natl Acad Sci U S A 2008; 105:6374-6379.
38. Tanriver Y, Ratnasothy K, Bucy RP, et al. Targeting MHC class I monomers to dendritic cells inhibits the indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term allograft survival. J Immunol 2010; 184:1757-1764.
39. Li D, Romain G, Flamar AL, et al. Targeting self-and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells. J Exp Med 2012; 209:109-121.
40. Jung KC, Park CG, Jeon YK, et al. In situ induction of dendritic cell-based T cell tolerance in humanized mice and nonhuman primates. J Exp Med 2011; 208:2477-2488.
41. Coates PT, Barratt-Boyes SM, Zhang L, et al. Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand. Blood 2003; 102:2513-2521.
42. Jesudason S, Collins MG, Rogers NM, et al. Nonhuman primate dendritic cells. J Leukoc Biol 2012; 91:217-228.
43. Moreau A, Chiffoleau E, Beriou G, et al. Superiority of bone marrow-derived dendritic cells over monocyte-derived ones for the expansion of regulatory T cells in the macaque. Transplantation 2008; 85:1351-1356.
44. Zahorchak AF, Raimondi G, Thomson AW. Rhesus monkey immature monocyte-derived dendritic cells generate alloantigen-specific regulatory T cells from circulating CD4+CD127-/lo T cells. Transplantation 2009; 88:1057-1064.
45. Zahorchak AF, Kean LS, Tokita D, et al. Infusion of stably immature monocytederived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. Transplantation 2007; 84:196-206.
46. Azimzadeh AM, Bromberg JS. Transplantation: negative vaccination to modulate transplant immunity. Nat Rev Nephrol 2013; 9:557-559.
47. Matsumoto T, Hasegawa H, Onishi S, et al. Protein kinase C inhibitor generates stable human tolerogenic dendritic cells. J Immunol 2013; 191:2247-2257.
48. Kleijwegt FS, Jansen DT, Teeler J, et al. Tolerogenic dendritic cells impede priming of naive CD8+ T cells and deplete memory CD8+ T cells. Eur J Immunol 2013; 43:85-92.
49. Naranjo-Gomez M, Raich-Regue D, Onate C, et al. Comparative study of clinical grade human tolerogenic dendritic cells. J Transl Med 2011; 9:89.
50. Boks MA, Kager-Groenland JR, Haasjes MS, et al. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction-a comparative study of human clinical-applicable DC. Clin Immunol 2012; 142:332-342.
51. Raich-Regue D, Grau-Lopez L, Naranjo-Gomez M, et al. Stable antigenspecific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients. Eur J Immunol 2012; 42:771-782.
52. Raich-Regue D, Glancy M, Thomson AW. Regulatory dendritic cell therapy: from rodents to clinical application. Immunol Lett 2013. [Epub ahead of print]
53. Giannoukakis N, Phillips B, Finegold D, et al. Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011; 34:2026-2032.
54. Thomas R. Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis. Arthritis Res Ther 2013; 15:204.
55. Hilkens CM, Isaacs JD. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? Clin Exp Immunol 2013; 172:148-157.